中文 | English
Return
Total: 68 , 1/7
Show Home Prev Next End page: GO
Author:(Chengliang LIU)

1.Epidemiological study on traditional Chinese medicine treatment for inflammatory bowel disease in Jiangsu Province from 2019 to 2023

Chujun NI ; Zexing LIN ; Haiyang JIANG ; Jie WU ; Peizhao LIU ; Jiaqi KANG ; Chengliang QIAN ; Haiqing LIU ; Liting DENG ; Huan YANG ; Chenling WU ; Yun ZHAO

Chinese Journal of Inflammatory Bowel Diseases 2025;09(4):318-325

2.Clinicopathological features of 12 cases of epithelioid hemangioendothelioma

Chengliang SUI ; Yanying SHEN ; Zebing LIU

Journal of Shanghai Jiaotong University(Medical Science) 2025;45(7):892-899

3.Clinicopathological features of 12 cases of epithelioid hemangioendothelioma

Chengliang SUI ; Yanying SHEN ; Zebing LIU

Journal of Shanghai Jiaotong University(Medical Science) 2025;45(7):892-899

4.Epidemiological study on traditional Chinese medicine treatment for inflammatory bowel disease in Jiangsu Province from 2019 to 2023

Chujun NI ; Zexing LIN ; Haiyang JIANG ; Jie WU ; Peizhao LIU ; Jiaqi KANG ; Chengliang QIAN ; Haiqing LIU ; Liting DENG ; Huan YANG ; Chenling WU ; Yun ZHAO

Chinese Journal of Inflammatory Bowel Diseases 2025;09(4):318-325

5.Expert consensus on the bi-directional screening for Mycobacterium tuberculosis and human immunodeficiency virus

Xin SHEN ; Yinzhong SHEN ; Eryong LIU ; Dingyong SUN ; Dongmin LI ; Yun HE ; Jinge HE ; Lin XU ; Bin CHEN ; Chengliang CHAI ; Lianguo RUAN ; Yong GAO ; Aihua DENG ; Zhen NING ; Jing CHEN ; Xiaofeng LIU ; Kaikan GU ; Lixin RAO

Shanghai Journal of Preventive Medicine 2024;36(4):327-336

6.Analysis of medical disputes related to drug-induced cross-allergy and study on prescripition review strategy

Wei LI ; Chengliang ZHANG ; Pinpin XUE ; Jinfeng DU ; Dong LIU

Chinese Journal of Pharmacoepidemiology 2024;33(1):2-8

7.Pharmacoeconomic evaluation of glucagon-like peptide-1 receptor agonist combined with metformin in the treatment of type 2 diabetes mellitus

Tian YU ; Shaohua LIU ; Anhua WEI ; Jieru GUO ; Chengliang ZHANG ; Dong LIU ; Zhelong LIU

Chinese Journal of Pharmacoepidemiology 2024;33(4):388-401

8.Efficacy and safety of glucagon-like peptide 1 receptor agonists in the treatment of overweight or obese patients with type 2 diabetes:a Meta-analysis

Tian YU ; Shaohua LIU ; Anhua WEI ; Jieru GUO ; Chengliang ZHANG ; Dong LIU ; Zhelong LIU

Chinese Journal of Pharmacoepidemiology 2024;33(5):519-538

9.Analysis of factors influencing the timing of laparoscopic operation in children with cryptorchidism

Haiwei LIN ; Haiyang LIU ; Chengliang LIU

Chinese Journal of Primary Medicine and Pharmacy 2024;31(6):846-852

10.Factors affecting the occurrence of cryptorchidism in children and the timing of surgery

Haiwei LIN ; Haiyang LIU ; Chengliang LIU

Chinese Journal of Primary Medicine and Pharmacy 2024;31(7):1022-1026

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 68 , 1/7 Show Home Prev Next End page: GO